Vektor Medical
Mike Monko is a seasoned executive with extensive experience in the biotechnology and life sciences sectors. As the Executive Chairman and Co-Founder of Vektor Medical, Inc., and former CEO and Co-Founder, Mike has demonstrated leadership and innovation. Previous roles include Senior Vice President at both Agena Bioscience and Sequenom, as well as Vice President of Sales at Upstate/Chemicon, which was acquired by Millipore, and Sr. Director of Sales at Life Technologies. Mike Monko holds an MBA from Babson College and a Bachelor of Science in Biochemistry from the University of New Hampshire.
This person is not in any teams
Vektor Medical
Developer of the world’s first technology to rapidly map arrhythmias anywhere in the heart using only 12-lead ECG data.